Enhanced Liver Fibrosis (ELF®) Test
The first and only blood test authorized in the U.S. for use as a prognostic marker in patients with advanced fibrosis due to MASH
Receive your quote directly from the manufacturer.
The ELF Test is a non-invasive blood test that measures three direct markers of fibrosis: hyaluronic acid (HA), procollagen III amino-terminal peptide (PIIINP), and tissue inhibitor of matrix metalloproteinase 1 (TIMP-1). The ELF Test, in conjunction with other laboratory and clinical findings, can be used to assess the risk of progression to cirrhosis and liver-related clinical events (LREs) in patients with advanced fibrosis due to MASH.
- Access non-invasive testing with a simple blood test available to all healthcare practitioners and patients, including those with type 2 diabetes mellitus and obesity.
- Assess risk of disease progression in patients with advanced fibrosis due to MASH before complications develop to help guide patient care.
- Enhance prognostic patient management with a test that has been shown to outperform biopsy for the risk assessment of progression to cirrhosis and LREs.
Clinical Chemistry Video of the Year: Addressing the rising prevalence of non-alcoholic fatty liver disease
The Scientists' Choice Award for Clinical Chemistry Video of the Year was awarded to Dr. Zobair M. Younossi, Professor and Chairman of the Department of Medicine at Inova Fairfax Hospital in Falls Church, Virginia. The winning video, first published on The Scientists' Channel discusses the epidemiology of non-alcoholic fatty liver disease (NAFLD) and addresses why there is a global need for more awareness and why the current approach to clinical care needs to change.
Find out more about Dr. Zobair M. Younossi's research on The Scientist's Channel>>
Your end of year playlist: 10 top videos on The Scientists’ Channel in 2019
We look back at a selection of this year’s best interviews with some of the world's leading experts
